Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home

Ipamorelin

A uniquely selective growth hormone booster that tells your pituitary to release more GH without messing with your cortisol or other hormones—making it the 'clean' choice among growth hormone peptides.

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards

Growth HormoneResearch compound

Suggested dose

100 – 300 mcg

Multiple times dailyCycle: 8-12 weeksOnset: Moderate (1-2 weeks)
2 hoursHalf-life
High when injected subcutaneouslyBioavailability
711.85 g/molMolecular weight
Moderate human trialsEvidence level

Compound profile

Scientific & efficacy data

Growth Hormone

Peptide profile

GH Selectivity9.8
Recovery Support9.0
Safety Profile9.2

Moderate human trials

Ipamorelin

100 mcg per injection · Multiple times daily

Molecular formula

C38H49N9O5

Mol. weight
711.85 g/mol
CAS number
170851-70-4
PubChem
9831659
Developed · 1998
Novo Nordisk Research Team
Novo Nordisk A/S (Denmark)

Amino acid sequence

Aib-His-D-2-Nal-D-Phe-Lys-NH2

GH Selectivity

Selective for GH release over ACTH and cortisol in conscious swine, holding at doses 200-fold above the GH ED50 [1]. Never measured in humans — neither published human study assayed those hormones [2][3].

Recovery Support

No human study has tested ipamorelin for workout recovery, sleep or tissue repair. In the one controlled human trial, trouble sleeping was more common on ipamorelin than on placebo — about 1 in 9 versus about 1 in 19 (10.7% vs 5.2%) [3][6]. The repair evidence is in rats: three months of ipamorelin restored bone formation and muscle strength in rats given a steroid that suppresses both [4], and it sped gut transit in a rat model of post-surgical ileus [5].

Safety Profile

Human exposure is limited to short courses — a single 15-minute IV infusion in the 40-volunteer pharmacokinetic study [2], and up to 7 days IV in the one Phase 2 trial, where low potassium, insomnia and high blood sugar were all more frequent than on placebo [3][6]. There is no data on long-term use, and none on the subcutaneous route.

Dosing

How much do I take?

100 – 300 mcg

100 – 300 mcg

Full Ipamorelin dosing protocol

Covers all 3 documented dose levels · timing · dose-adjustment guidance.

Ipamorelin2-3 times daily

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to mg — like "5 mg".

Type a number to continue.
0

Suitability

Is this right for me?

Best for muscle recovery and growth & anti-aging and vitality

Best for

Clean GH Boost Seekers

If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release.

Recovery-Focused Athletes

Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects.

Anti-Aging Enthusiasts

Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy.

Those Recovering from Steroid Use

Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost.

Consider alternatives if

Maximum GH release (less selective)GHRP-6, GHRP-2, Hexarelin
Oral convenience over injectionsMK-677 (Ibutamoren), Sermorelin nasal spray
Combined GHRH + GHRP effectCJC-1295/Ipamorelin blend, Sermorelin/Ipamorelin blend, Tesamorelin

Do not use if

You have active cancer or a history of cancer—GH can potentially fuel tumor growthYou are pregnant or might become pregnant—effects on fetal development are unknownYou are breastfeeding—peptide could potentially pass into breast milkYou have a pituitary tumor or disorder—could worsen the conditionYou have uncontrolled diabetes—GH can affect blood sugar regulationYou're under 18—growth plates are still active and shouldn't be manipulated

Use with caution if

You have diabetes or prediabetes—monitor blood sugar closely as GH affects glucoseYou're on blood pressure medications—some users experience changesYou have carpal tunnel syndrome—GH can worsen symptoms temporarilyYou take thyroid medications—GH may affect thyroid hormone conversionYou have a history of joint problems—GH can initially cause joint discomfortYou're over 65—start with lower doses and monitor carefully

Not sure?

Compare Ipamorelin with similar peptides to find the best fit for your goals.

Administration

How do I use it?

Subcutaneous injection

Route

Subcutaneous injection (just under the skin)—quick, easy, and most effective for peptides like Ipamorelin

Best sites

Belly fat area (about 2 inches from your belly button)Front or outer thigh (middle section)Back of the upper arm (pinch the skin if needed)

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is it safe?

4 common side effects · 1 serious

Ipamorelin's main selling point is that it raises growth hormone without raising cortisol or ACTH — two stress hormones that similar peptides do raise.

That was shown in pigs, and it held even at doses more than 200 times higher than the amount needed to raise growth hormone [1]. It has not been checked in people. The two published human studies measured ipamorelin and growth hormone only; neither one assayed cortisol, ACTH or prolactin [2][3].

Most of what we know about safety in people comes from a single trial in patients recovering from bowel surgery. 114 people took part: 56 got ipamorelin through an IV for up to seven days, and 58 got a placebo.

Most side effects were mild to moderate, and were the kind you would expect after surgery [3]. Serious problems happened at about the same rate in both groups — roughly 1 in 6 either way (17.9% on ipamorelin, 15.5% on placebo).

But three things were more common on ipamorelin: low potassium in about 1 in 8 people versus about 1 in 30 on placebo (12.5% vs 3.4%), trouble sleeping in about 1 in 9 versus about 1 in 19 (10.7% vs 5.2%), and high blood sugar at discharge in about 1 in 7 versus about 1 in 12 (14.3% vs 8.6%) [6].

Two people taking ipamorelin died. Both had colon cancer surgery, and in both cases the surgical join in the bowel leaked afterward. Nobody on the placebo died.

The FDA says it is unclear whether those deaths had anything to do with ipamorelin — but it pointed to them, along with the potassium and blood sugar differences, when it recommended in October 2024 against letting pharmacies compound ipamorelin [6].

Ipamorelin has been tested in people more than most research peptides, and far less than an approved medicine.

There is early work measuring how it moves through the body — 40 healthy men across five dose levels, given by IV infusion, which is where the roughly 2-hour half-life comes from [2] — plus the one trial in surgery patients [3]. That trial did not work.

It was built to see whether ipamorelin got the gut moving again faster after surgery.

People on ipamorelin ate their first solid meal about 7 hours sooner — 25.3 hours versus 32.6 hours — but that difference was small enough that it could easily have been chance, and none of the other measures separated from placebo either. The company stopped developing it for that use [3].

The 1998 study behind the "selective" label was done in rat pituitary cells, in rats, and in pigs, not in people [1]. Ipamorelin is not approved for anything, and in October 2024 the FDA recommended against adding it to the list of substances pharmacies are allowed to compound [6].

Common side effects · experienced by some users

  • Mild headache

    Some users experience headaches in the first few days to weeks. This usually relates to your body adjusting to increased GH pulses.

    Management: Stay well-hydrated, start with lower doses, and it typically resolves within the first 1-2 weeks.

  • Injection site reactions

    Redness, minor swelling, or itching at the injection site is normal and harmless.

    Management: Rotate injection sites between belly, thigh, and arm. A cool compress can help. Usually fades within hours.

  • Water retention

    Mild bloating or puffiness, especially in the first few weeks. This is a known GH effect that usually stabilizes.

    Management: Reduce sodium intake, stay hydrated, and give your body 2-3 weeks to adjust. Consider slightly lower doses if significant.

  • Increased appetite

    Ipamorelin activates the ghrelin receptor, which can stimulate hunger—the same receptor that makes your stomach growl.

    Management: Plan your meals around injection times. This effect can actually be useful if you're trying to gain muscle and need to eat more.

Less common

Tingling in hands or feetJoint stiffness

These typically resolve with continued use or dose adjustment.

Stop and seek help if

  • Any signs of allergic reaction—stop immediately and seek medical help
  • Persistent carpal tunnel symptoms that worsen despite dose reduction
  • Significant joint pain that interferes with daily activities
  • Blood sugar control becomes significantly harder to manage
  • Unusual swelling that doesn't resolve with lower doses
  • Any side effect that feels serious or really concerns you

Ipamorelin is a research compound, not an FDA-approved medication. Never start, stop, or change your dosing without guidance from a qualified healthcare provider. This information is for educational purposes only—not medical advice.

With other peptides

  • Safe:CJC-1295 (with or without DAC) — Excellent synergistic pairing. CJC-1295 provides the GHRH signal while Ipamorelin amplifies it through the ghrelin receptor. Inject together for best results.
  • Safe:Sermorelin — Another great pairing. Both stimulate GH but through different mechanisms, creating a more robust natural GH pulse.
  • Safe:BPC-157 — Safe to combine for enhanced recovery. BPC-157 handles tissue repair while Ipamorelin boosts overall GH for systemic recovery.
  • Safe:TB-500 — Complementary for healing. Inject at different sites but can use on the same day.
  • Safe:GHRP-6 — Usually redundant since both hit the ghrelin receptor. Ipamorelin is preferred for its selectivity. Using both together is unnecessary.

With medications

  • Caution:Insulin — GH can affect insulin sensitivity. Diabetics need to monitor blood sugar closely and may need insulin adjustments. Consult your doctor.
  • Caution:Diabetes medications (metformin, etc.) — GH affects glucose metabolism. Monitor blood sugar more frequently and inform your doctor.
  • Safe:Thyroid medications — GH can affect T4 to T3 conversion. May need thyroid level monitoring if on thyroid replacement.
  • Safe:Glucocorticoids (prednisone, etc.) — Actually potentially beneficial—research shows Ipamorelin can help counter steroid-induced muscle and bone loss. Discuss with your doctor.
  • Safe:Blood pressure medications — Some users experience BP changes with GH peptides. Monitor blood pressure regularly.

With supplements

  • Safe:Arginine — Can enhance GH release when taken separately. Some people take arginine at different times to compound effects.
  • Safe:GABA — Safe to combine—GABA may support additional GH release, especially when taken before bed.
  • Safe:Melatonin — Safe and potentially synergistic for sleep quality and nighttime GH release.
  • Safe:High-dose glucose or carbs — Blood sugar spikes blunt GH release. Avoid carbs around injection times for best results.

Effectiveness

How do I know it's working?

Moderate human trials · first signs week 1-2

Evidence level

Moderate human trials

(Phase 1-2)

80/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)

How it works

Think of your pituitary gland as a GH factory that's controlled by two signals: one that says 'make more!'

(GHRH) and one that says 'slow down!' (somatostatin). Ipamorelin works like pressing the gas pedal without also triggering the alarm system.

It binds to the ghrelin receptor (the same one that tells you you're hungry), which signals your pituitary to release growth hormone in natural pulses—just like your body does when you're young. What makes Ipamorelin special is that it ONLY does this one job.

Other similar peptides also accidentally boost stress hormones like cortisol, but Ipamorelin is laser-focused on GH alone.

The deeper mechanism

Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a pentapeptide growth hormone secretagogue that selectively activates the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.

Unlike endogenous ghrelin or other synthetic GHRPs (GHRP-6, GHRP-2, hexarelin), ipamorelin demonstrates remarkable selectivity for GH release without significant effects on ACTH, cortisol, prolactin, or aldosterone.

This selectivity was demonstrated at doses over 200-fold higher than the ED50 for GH release. The mechanism involves GHS-R1a activation on pituitary somatotrophs, triggering phospholipase C, IP3/DAG signaling, calcium mobilization, and ultimately exocytosis of GH-containing vesicles.

Additionally, GHS-R1a activation on hypothalamic neurons may inhibit somatostatin release, further amplifying the GH response.

The peptide exhibits dose-proportional pharmacokinetics with a terminal half-life of approximately 2 hours, clearance of 0.078 L/h/kg, and volume of distribution of 0.22 L/kg. The SC50 for half-maximal GH stimulation is 214 nmol/L with maximal GH production rate of 694 mIU/L/h.

What to expect

  1. Week 1-2

    What you might notice

    • Possibly better sleep quality, especially with the bedtime dose
    • Mild headache or injection site reactions (normal)
    • Slight increase in appetite
    • Some temporary water retention or bloating

    What's normal

    • Adjusting to the injection routine
    • Minor side effects that resolve on their own
    • No dramatic visible changes yet

    What's next

    • Continue consistent dosing timing
    • Track any effects in a simple log
    • Side effects typically improve by end of week 2
  2. Week 3-4

    What you might notice

    • More consistent, deeper sleep
    • Improved workout recovery—less soreness, faster bounce-back
    • Side effects usually stabilize or resolve
    • Possible subtle improvements in skin quality

    What's normal

    • Starting to feel the benefits
    • Water retention typically stabilizes
    • Getting into a comfortable routine

    What's next

    • Consider increasing dose if on starting protocol with no issues
    • Continue tracking progress
    • Focus on nutrition and training to maximize benefits
  3. Week 5-8

    What you might notice

    • Noticeable improvements in body composition with proper diet/training
    • Enhanced recovery becoming clearly apparent
    • Better energy and vitality
    • Improved skin elasticity and quality
    • Potential fat loss, especially with caloric deficit

    What's normal

    • Steady, gradual improvements rather than dramatic changes
    • Benefits compound with consistent use
    • Most side effects resolved by now

    What's next

    • Continue through 8-12 week cycle
    • Consider blood work to monitor IGF-1 and health markers
    • Plan your next cycle or maintenance approach
  4. Week 9-12+

    What you might notice

    • Peak benefits typically experienced
    • Significant improvements in lean mass and fat loss with proper training
    • Sustained energy and recovery improvements
    • Possible plateau as your body adapts

    What's normal

    • Benefits stabilizing at their new baseline
    • Some people cycle off for 4-8 weeks, others continue
    • Considering whether to maintain, cycle off, or adjust

    What's next

    • Evaluate results and decide on next steps
    • Some users take a 4-8 week break then resume
    • Others continue with maintenance dosing

Signs it's working

Sleep and Recovery

  • Falling asleep more easily at night
  • Waking up feeling more refreshed and rested
  • Deeper, more restorative sleep
  • Faster recovery between workouts
  • Less muscle soreness after training

Body Composition

  • Gradual reduction in body fat, especially around the midsection
  • Improved muscle tone and definition
  • Better muscle pumps during workouts
  • Clothes fitting differently (tighter in good places, looser around waist)

Skin and Appearance

  • Improved skin elasticity and hydration
  • Reduction in fine lines over time
  • Healthier hair quality
  • Overall more youthful appearance

Lab Markers (if tested)

  • Elevated IGF-1 levels on blood work
  • Stable or improved lipid profiles
  • Maintained healthy blood sugar levels

Not seeing results? Common reasons

  • Eating too close to injection—food, especially carbs, blunts GH release. Always inject fasted.
  • Inconsistent dosing schedule—GH peptides work best with consistent timing to establish rhythmic release
  • Poor quality peptide from unreliable source—always verify third-party testing certificates (COAs)
  • Improper storage degraded the peptide—check that solution is crystal clear before using
  • Unrealistic expectations—Ipamorelin provides gradual, natural improvements, not overnight transformations
  • Not supporting with proper nutrition and exercise—peptides enhance your lifestyle, they don't replace it
  • Blood sugar too high at injection time—insulin spikes inhibit GH release

Key research

1998[1]
“Ipamorelin, the first selective growth hormone secretagogue”Raun K, Hansen BS, Johansen NL, et al.Finding: This Novo Nordisk study introduced ipamorelin as the first GH secretagogue selective for GH release. Potency was measured in primary rat pituitary cells and in rats; selectivity was tested in conscious swine, where — unlike GHRP-6 and GHRP-2 — ipamorelin did not raise ACTH or cortisol above the levels seen with GHRH, and that held at doses more than 200-fold above the ED50 for GH release. No human study has since measured ACTH, cortisol or prolactin after ipamorelin, so the selectivity finding remains animal data.View study
1999[2]
“Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers”Gobburu JV, Agersø H, Jusko WJ, Ynddal LFinding: This human clinical trial established Ipamorelin's pharmacokinetics—showing a 2-hour half-life, dose-proportional responses, and consistent GH release across all dose levels tested. The study provided the foundation for understanding proper human dosing.View study
2014[3]
“Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients”Beck DE, Sweeney WB, McCarter MD, et al.Finding: This Phase 2 proof-of-concept trial randomized 114 bowel-resection patients (56 ipamorelin, 58 placebo) to IV study drug twice daily for up to 7 days. It did not meet its primary endpoint: median time to first tolerated meal was 25.3 hours on ipamorelin vs 32.6 hours on placebo, a 7.3-hour difference that was not statistically significant, with no significant separation on secondary endpoints. Most adverse events were mild to moderate and attributed to surgery. Serious adverse events occurred in 17.9% of ipamorelin patients vs 15.5% on placebo; hypokalemia (12.5% vs 3.4%), insomnia (10.7% vs 5.2%) and hyperglycemia at discharge (14.3% vs 8.6%) were more common on ipamorelin, and two ipamorelin-treated patients died after anastomotic leak. FDA's 2024 review states it is unclear whether those deaths were related to ipamorelin. The authors advised interpreting the results with caution given the small sample size.View study
2001[4]
“The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats”Andersen NB, Malmlöf K, Johansen PB, et al.Finding: This study showed Ipamorelin can counteract the muscle and bone damage caused by glucocorticoid (steroid) medications. Rats on steroids plus Ipamorelin had significantly increased muscle strength and four times greater bone formation compared to steroids alone.View study
2009[5]
“Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus”Venkova K, Mann W, Nelson R, Greenwood-Van Meerveld BFinding: Repeated Ipamorelin dosing significantly improved gut motility, food intake, and body weight recovery after surgery in rats. This supports its potential use for post-surgical recovery beyond just GH benefits.View study
2024[6]
“Ipamorelin: FDA Pharmacy Compounding Advisory Committee briefing document”U.S. Food and Drug AdministrationFinding: FDA's review of ipamorelin ahead of the 29 October 2024 advisory committee meeting. It reports the per-arm adverse event rates from the Phase 2 bowel-resection trial that the journal abstract does not: serious adverse events in 10 of 56 on ipamorelin (17.9%) versus 9 of 58 on placebo (15.5%); hypokalemia 12.5% versus 3.4%; insomnia 10.7% versus 5.2%; hyperglycemia at discharge 14.3% versus 8.6%. Two ipamorelin-treated patients died of postoperative complications after anastomotic leak following colon cancer resection, and none on placebo. FDA states "it is unclear whether the two deaths were related to ipamorelin," and cited them alongside the potassium and glucose imbalances in recommending against adding ipamorelin to the 503A compounding list.View study

Clinical trials

Tested in people

2 registered studies, none currently enrolling.

2registered studies
0recruiting now
0phase 3 or 4
1with published results

By phase

Phase 22

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug2
Records only0

About 437 people took part in the studies that actually administered Ipamorelin. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.

Most recent

  • NCT01280344Phase 2Completed320 enrolled

    Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

    Helsinn Therapeutics (U.S.), Inc

  • NCT00672074Phase 2Completed117 enrolled

    Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

    Helsinn Therapeutics (U.S.), Inc

See all 2 trials for Ipamorelin

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Ipamorelin is named as an intervention; studies that only mention it in passing are not.

Questions

Frequently asked

What makes Ipamorelin different from other GH peptides like GHRP-6?

Ipamorelin is uniquely selective—it only releases growth hormone without spiking cortisol, ACTH, or prolactin like other peptides do. Even at doses 200 times higher than needed for GH release, it doesn't affect these other hormones. This makes it the 'cleanest' choice with fewer side effects and hormonal disruptions.

How long does it take to see results from Ipamorelin?

Most people notice improved sleep quality within the first 1-2 weeks. Recovery benefits typically become apparent by weeks 3-4. Body composition changes (fat loss, muscle improvements) usually take 6-12 weeks of consistent use combined with proper diet and exercise. It's a gradual process, not an overnight transformation.

Why do I need to inject multiple times per day?

Ipamorelin has a short half-life of about 2 hours, meaning it clears your system quickly. Multiple injections throughout the day create multiple GH pulses, mimicking how your body naturally releases growth hormone. This pulsatile pattern is more effective and natural than one big dose.

Can I take Ipamorelin with food?

You should NOT take it with food. Eating—especially carbohydrates—causes insulin release, which blunts your GH response. Always inject on an empty stomach (ideally first thing in morning, 2+ hours after meals, or before bed) and wait at least 30 minutes before eating.

Is Ipamorelin the same as HGH?

No, they're quite different. HGH (human growth hormone) is the actual hormone injected directly. Ipamorelin signals your own pituitary gland to release more of YOUR natural GH. This creates a more natural pulsatile release pattern and lets your body maintain its feedback systems. It's gentler and generally has fewer side effects than exogenous HGH.

Should I combine Ipamorelin with CJC-1295?

Many people do, and it's a popular combination. CJC-1295 mimics GHRH (the hormone that tells your pituitary to make GH), while Ipamorelin works through the ghrelin receptor. Together, they amplify each other's effects through two different pathways. You can inject them at the same time for convenience.

Will Ipamorelin make me hungry all the time?

It can increase appetite since it activates the same receptor that makes you feel hungry (the ghrelin receptor). However, this effect is usually mild and some people find it helpful if they're trying to eat more for muscle building. If hunger is problematic, it typically becomes less noticeable after the first few weeks.

Is Ipamorelin legal?

Ipamorelin is not FDA approved and is classified as a research compound. It's legal to purchase for research purposes in many countries, but it's not approved for human medical use. Athletes should note that it's banned by WADA and most sports organizations. Always check your local regulations.

Further reading

History & related research

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Ipamorelin, on one page.

Medical disclaimer

Ipamorelin is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Aug 10, 2026